Erythrocytapheresis as a novel treatment option for adult patients with pyruvate kinase deficiency
Open Access
- 9 April 2020
- journal article
- editorial
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 105 (7), e373-e375
- https://doi.org/10.3324/haematol.2020.246686
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Red Blood Cells: Exchange, Transfuse, or DepleteTransfusion Medicine and Hemotherapy, 2019
- Selecting red blood cell units to perform RBCX in patients with sickle cell diseaseTransfusion and Apheresis Science, 2019
- How we manage patients with pyruvate kinase deficiencyBritish Journal of Haematology, 2019
- Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History StudyBlood, 2018
- Erythrocyte pyruvate kinase deficiency: 2015 status reportAmerican Journal of Hematology, 2015
- Red cell pyruvate kinase deficiency: molecular and clinical aspectsBritish Journal of Haematology, 2005
- Bilirubin Turnover Studies in Normal and Pathologic States Using Bilirubin-^14CAnnals of Internal Medicine, 1968